Literature DB >> 22531522

Correlation of fluorodeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas.

Yi Shou1, Jianping Lu, Tao Chen, Dalie Ma, Linjun Tong.   

Abstract

OBJECTIVE: To investigate the correlation between cellular proliferation and the fluorodeoxyglucose (FDG) uptake in positron emission tomography/computed tomography (PET/CT) imaging by comparing 50 cases of different subtypes of lymphoma.
MATERIALS AND METHODS: Fifty cases of lymphomas were collected. Each case was labeled with Ki-67 stain, a marker of cellular proliferation, and a PET/CT examination was performed. All lymphoma cases were sorted according to the World Health Organization's classification, and the International Non-Hodgkin's Lymphoma Working Formulation was used to differentiate groups of large and small cell non-Hodgkin's lymphoma. The Ki-67 staining was described as slight, mild, middle, or strong according to the nuclear staining of positive cells. FDG uptake by lesions in PET/CT images was semi-quantitatively analyzed to calculate the average standard uptake value. The statistics software SPSS13.0 was used to calculate the mean and standard deviation of the FDG uptake value of the lymphoma subtypes, the difference between the large and small cell lymphoma group with a Student's t-test, and the correlation between the Ki-67 level and FDG uptake of lesion with a Spearman's analysis.
RESULTS: The FDG uptake value of large cell origin lymphoma was significantly higher than that of small cell origin lymphoma (t = 6.19, P < 0.01). The correlation coefficients between the Ki-67 level and FDG uptake value in lymph nodal and extranodal lesions was 0.750 and 0.843, respectively.
CONCLUSIONS: Ki-67 staining, a reflection of tumor-proliferation activity, was significantly related to the FDG uptake value in lymphoma lesions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531522     DOI: 10.4103/0973-1482.95182

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  9 in total

1.  Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.

Authors:  L Heijmen; C J A Punt; E G W Ter Voert; L F de Geus-Oei; A Heerschap; J Bussink; C G J Sweep; V Zerbi; W J G Oyen; P N Span; O Boerman; H W M van Laarhoven
Journal:  Invest New Drugs       Date:  2013-01-17       Impact factor: 3.850

2.  Notch-1 and Ki-67 receptor as predictors for the recurrence and prognosis of Kimura's disease.

Authors:  Wei-Ye Deng; Shu-Biao Ye; Rong-Zhen Luo; Shu-Mei Yan; Yun-Fei Gao; Yuan-Zhong Yang; Zhu-Ming Guo; Yan-Feng Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

3.  Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.

Authors:  Sheng-Ming Deng; Wei Zhang; Bin Zhang; Yin-Yin Chen; Ji-Hui Li; Yi-Wei Wu
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

4.  Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma.

Authors:  Xingchen Wu; Hannu Pertovaara; Pasi Korkola; Prasun Dastidar; Ritva Järvenpää; Hannu Eskola; Pirkko-Liisa Kellokumpu-Lehtinen
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  False Negative 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Primary B-cell Lymphoma of the Bone.

Authors:  Matthieu Pelletier-Galarneau; Patrick Martineau; Raymond Lambert; Sophie Turpin
Journal:  World J Nucl Med       Date:  2017 Apr-Jun

6.  Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma.

Authors:  Xuejin Ou; Jian Wang; Ruofan Zhou; Sha Zhu; Fuwen Pang; Yi Zhou; Rong Tian; Xuelei Ma
Journal:  Contrast Media Mol Imaging       Date:  2019-02-25       Impact factor: 3.161

Review 7.  The metabolic fate of acetate in cancer.

Authors:  Zachary T Schug; Johan Vande Voorde; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

8.  Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Ai Inoue; Hiroki Katsushima; Rie Ohba; Yuna Katsuoka; Yasushi Onishi; Joji Yamamoto; Osamu Sasaki; Jun Nomura; Osamu Fukuhara; Kenichi Ishizawa; Ryo Ichinohasama; Hideo Harigae
Journal:  Exp Hematol Oncol       Date:  2013-08-02

9.  Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis.

Authors:  Kamilla Westarp Zornhagen; Anders E Hansen; Jytte Oxboel; Andreas E Clemmensen; Henrik H El Ali; Annemarie T Kristensen; Andreas Kjær
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.